Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Clinical trial NCT02579369 · COMPLETED
Trial details
- NCT number
- NCT02579369
- Sponsor
- Anterogen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2016-04-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.